Can Dynamic Susceptibility Contrast Perfusion Imaging be Utilized to Detect Isocitrate Dehydrogenase Gene Mutation in Gliomas?

Kilincer, Abidin; Cebeci, Hakan; Seher, Nusret; Durmaz, Mehmet Sedat; Uysal, Emine; Sahinoglu, Mert; Koktekir, Ender; Karabagli, Hakan; Karabagli, Pinar; Paksoy, Yahya

Kilincer, Abidin; Cebeci, Hakan; Seher, Nusret; Durmaz, Mehmet Sedat; Uysal, Emine; Sahinoglu, Mert; Koktekir, Ender; Karabagli, Hakan; Karabagli, Pinar; Paksoy, Yahya.

Affiliation

Kilincer A; Selcuk University, Faculty of Medicine, Department of Radiology, Konya, Turkey.

Turk Neurosurg ; 32(5): 826-833, 2022.

Article in En | MEDLINE | ID: mdl-35713257

Subject(s)

Brain Neoplasms; Glioma; Adult; Aged; Brain Neoplasms/diagnostic imaging; Brain Neoplasms/genetics; Brain Neoplasms/pathology; Female; Glioma/diagnostic imaging; Glioma/genetics; Humans; Isocitrate Dehydrogenase/genetics; Magnetic Resonance Imaging/methods; Male; Middle Aged; Mutation; Perfusion Imaging; Retrospective Studies; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioma Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Turk Neurosurg Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google